1-(3-Bromo-4-methylphenyl)ethan-1-amine

Catalog No.: 
ACSDAX120
CAS No.: 
90485-17-9
Molecular Formula: 
C9H12BrN
Molecular Weight: 
214.11
1-(3-Bromo-4-methylphenyl)ethan-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$353.00InquiryInquiry
250mg95%$648.00InquiryInquiry
1g95%$1620.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Bromo-4-methylphenyl)ethan-1-amine
IUPAC Name1-(3-bromo-4-methylphenyl)ethan-1-amine
MDL No.MFCD18710244
Molecular FormulaC9H12BrN
Molecular Weight214.11
SMILESCC(N)C1=CC=C(C)C(Br)=C1
InChI KeyQZOVGJPADSENQV-UHFFFAOYSA-N
Synonym1-(3-BROMO-4-METHYLPHENYL)ETHAN-1-AMINE;1-(3-bromo-4-methylphenyl)ethanamine;3-Bromo-α,4-dimethylbenzenemethanamine
CAS No.90485-17-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACSDAX120 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVOKC062 route compound structure diagram
    ACVOKC06240180-80-1In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACSDAX120 route product structure diagram
    ACSDAX12090485-17-9
Inquiry

2. ACSDAX120 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVOKC062 route compound structure diagram
    ACVOKC06240180-80-1In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACSDAX120 route product structure diagram
    ACSDAX12090485-17-9
Inquiry

3. ACSDAX120 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSDAX120 route product structure diagram
    ACSDAX12090485-17-9
Inquiry

Comments (0)